We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
+8.19%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$73.1B
AUM Growth
+$2.4B
Cap. Flow
-$1.43B
Cap. Flow %
-1.96%
Top 10 Hldgs %
11.25%
Holding
4,601
New
626
Increased
1,390
Reduced
2,018
Closed
524

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$839M
2
AMZN icon
Amazon
AMZN
+$810M
3
TSLA icon
Tesla
TSLA
+$644M
4
TSM icon
TSMC
TSM
+$546M
5
JNJ icon
Johnson & Johnson
JNJ
+$389M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$891M
2
HD icon
Home Depot
HD
+$441M
3
JPM icon
JPMorgan Chase
JPM
+$335M
4
NVO
Novo Nordisk
NVO
+$317M
5
ASML icon
ASML
ASML
+$315M

Sector Composition

Rank Sector Weight
1 Healthcare 20.81%
2 Technology 15.51%
3 Consumer Discretionary 11.84%
4 Consumer Staples 10.09%
5 Financials 9.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEAR
3851
DELISTED
Pear Therapeutics, Inc. Class A Common Stock
PEAR
$38K ﹤0.01%
32,300
-18,800
-37% -$39.5K
EJH icon
3852
E-Home Household Service Holdings
EJH
$3.94M
0
NEPH icon
3853
Nephros
NEPH
$38.2M
$37K ﹤0.01%
32,064
+9,764
+44% +$10.4K
PTN
3854
Palatin Technologies
PTN
$14.6M
$37K ﹤0.01%
291
+22
+8% +$4.73K
RMTI icon
3855
Rockwell Medical
RMTI
$28.5M
$37K ﹤0.01%
3,693
-29
-0.8% -$310
SKYA
3856
SkyAI Inc
SKYA
$55.4M
$37K ﹤0.01%
5
-1
-17% -$7.75K
AVGR
3857
DELISTED
Avinger, Inc. Common Stock
AVGR
$37K ﹤0.01%
2,245
+54
+2% +$921
MRIN
3858
DELISTED
Marin Software
MRIN
$36K ﹤0.01%
6,019
-31,598
-84% -$220K
RZLT icon
3859
Rezolute
RZLT
$482M
$36K ﹤0.01%
17,600
+400
+2% +$749
XOS icon
3860
Xos
XOS
$31M
$36K ﹤0.01%
+2,690
New +$69.3K
HMPT
3861
DELISTED
Home Point Capital, Inc Common Stock
HMPT
$36K ﹤0.01%
26,500
-300
-1% -$463
TCDA
3862
DELISTED
Tricida, Inc. Common Stock
TCDA
$36K ﹤0.01%
238,100
+221,074
+1,298% +$657K
RIBT
3863
DELISTED
RiceBran Technologies
RIBT
$36K ﹤0.01%
48,268
-700
-1% -$836
BDRX
3864
Biodexa Pharmaceuticals
BDRX
$1.28M
0
FORA
3865
DELISTED
Forian
FORA
$35K ﹤0.01%
12,800
MITQ icon
3866
Moving iMage Technologies
MITQ
$5.36M
$35K ﹤0.01%
30,400
-20,600
-40% -$22.7K
RUBY
3867
DELISTED
Rubius Therapeutics, Inc
RUBY
$35K ﹤0.01%
200,190
+71,600
+56% +$19.6K
ASAP
3868
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
$35K ﹤0.01%
100,330
+25,080
+33% +$46.8K
SDEV
3869
Stablecoin Development Corp
SDEV
$55M
$34K ﹤0.01%
100
+24
+32% +$11.2K
UNAM
3870
DELISTED
Unico American Corp
UNAM
$34K ﹤0.01%
20,737
-900
-4% -$1.16K
CPHI icon
3871
China Pharma Holdings
CPHI
$45.8M
$33K ﹤0.01%
681
-48
-7% -$2.93K
IH
3872
iHuman
IH
$69M
$33K ﹤0.01%
+12,500
New +$25.4K
SERA icon
3873
Sera Prognostics
SERA
$82.2M
$33K ﹤0.01%
26,400
-40,940
-61% -$57.8K
ENG
3874
DELISTED
ENGlobal Corp
ENG
$33K ﹤0.01%
+5,288
New +$41.1K
ELYS
3875
DELISTED
Elys Game Technology, Corp. Common Stock
ELYS
$33K ﹤0.01%
117,900
+4,600
+4% +$1.26K

Similar funds

Renaissance Technologies's Q4 2022 Portfolio in Review

As of Q4 2022, Renaissance Technologies held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Renaissance Technologies's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Renaissance Technologies's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
  • Renaissance Technologies added most to Apple in Q4 2022, an estimated $839M increase.
  • Renaissance Technologies's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
  • Renaissance Technologies fully exited Microsoft in Q4 2022, selling an estimated $891M.
  • Renaissance Technologies's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
  • Renaissance Technologies opened 626 new positions and closed 524 in Q4 2022.
  • Renaissance Technologies's portfolio value rose 3.4% quarter-over-quarter to $73.1B.

Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.